# Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

> **NCT07136415** · PHASE4 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Menopausal Women
- Insomnia

## Interventions

- **BEHAVIORAL:** Cognitive behavioral therapy for insomnia (CBT-i)
- **DRUG:** Trazodone
- **DRUG:** Daridorexant

## Key facts

- **NCT ID:** NCT07136415
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-13
- **Primary completion:** 2031-02
- **Final completion:** 2031-02
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07136415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07136415, "Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07136415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*